Filing Details

Accession Number:
0001127602-19-011378
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-14 17:07:35
Reporting Period:
2019-03-12
Accepted Time:
2019-03-14 17:07:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670040 Aiman Abdel-Malek C/o Insulet Corporation
100 Nagog Park
Acton MA 01720
Evp & Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-12 19,915 $31.20 43,907 No 4 M Direct
Common Stock Acquisiton 2019-03-12 5,686 $46.22 49,593 No 4 M Direct
Common Stock Acquisiton 2019-03-12 1,748 $74.50 51,341 No 4 M Direct
Common Stock Disposition 2019-03-12 27,349 $94.03 23,992 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-12 19,915 $0.00 19,915 $31.20
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-12 5,686 $0.00 5,686 $46.22
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-03-12 1,748 $0.00 1,748 $74.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,967 2026-03-28 No 4 M Direct
5,686 2027-02-22 No 4 M Direct
5,247 2028-02-14 No 4 M Direct
Footnotes
  1. Includes 4,674 restricted stock units granted on March 28, 2016, which vest on March 28, 2019; 4,006 performance share units granted on March 28, 2016, which vest on March 28, 2019; 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $93.67 to $94.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.